Destiny Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Destiny Wealth Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-394	Closed	-$31.6K	–	445
2026 Q1	$31.6K	Buy	+394	New	+$32.5K	﹤0.01%	536
2023 Q1	–	Sell	-174	Closed	-$13K	–	324
2022 Q4	$13K	Buy	174 +10	+6%	+$771	﹤0.01%	448
2022 Q3	$14K	Hold	164	–	–	﹤0.01%	393
2022 Q2	$16K	Buy	+164	New	+$17K	﹤0.01%	382
2021 Q2	–	Sell	-63	Closed	-$5K	–	285
2021 Q1	$5K	Hold	63	–	–	﹤0.01%	453
2020 Q4	$6K	Buy	+63	New	+$5.23K	﹤0.01%	442

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Destiny Wealth Partners's EW Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 394 shares — an estimated $31.6K sold.

Destiny Wealth Partners first reported a position in EW in Q4 2020 and held it in 6 quarters. The position peaked at $31.6K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Destiny Wealth Partners reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
Destiny Wealth Partners sold 394 Edwards Lifesciences shares in Q2 2026, an estimated $31.6K.
Destiny Wealth Partners first reported a position in Edwards Lifesciences in Q4 2020 and held it in 6 quarters.
Destiny Wealth Partners's Edwards Lifesciences position peaked at $31.6K in Q1 2026.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.